{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:24:57Z","timestamp":1762521897582},"reference-count":73,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.lpm.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T01:08:14Z","timestamp":1464656894000},"page":"e159-e169","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"P2","title":["Stem cell transplantation and mesenchymal cells to treat autoimmune diseases"],"prefix":"10.1016","volume":"45","author":[{"given":"Alan","family":"Tyndall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2016.05.002_bib0370","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/ard.55.10.779","article-title":"Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease","volume":"55","author":"Tamm","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2016.05.002_bib0375","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/ard.55.3.149","article-title":"Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases","volume":"55","author":"Tyndall","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2016.05.002_bib0380","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bmt.2011.185","article-title":"Haematopoietic\u00a0SCT in severe autoimmune diseases: updated guidelines of the European group for blood and marrow transplantation","volume":"47","author":"Snowden","year":"2012","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.lpm.2016.05.002_bib0385","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2009.013458","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12\u00a0years\u2019 experience from the European group for blood and marrow transplantation working party on autoimmune diseases","volume":"95","author":"Farge","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.lpm.2016.05.002_bib0390","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.bbmt.2012.06.003","article-title":"Transplantation for autoimmune diseases in north and South America: a report of the Center for international blood and marrow transplant research","volume":"18","author":"Pasquini","year":"2012","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.lpm.2016.05.002_bib0395","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/rheumatology\/kel158","article-title":"Adult stem cells in the treatment of autoimmune diseases","volume":"45","author":"van Laar","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2016.05.002_bib0400","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/sj.bmt.1704892","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases","volume":"35","author":"Gratwohl","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lpm.2016.05.002_bib0405","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2016.05.002_bib0410","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","article-title":"Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients","volume":"201","author":"Muraro","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2016.05.002_bib0415","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/08916930802200182","article-title":"Regulatory\u00a0T cells in autologous stem cell transplantation for autoimmune disease","volume":"41","author":"van Wijk","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.lpm.2016.05.002_bib0420","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","article-title":"High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study","volume":"110","author":"Nash","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2016.05.002_bib0425","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/ard.2007.082008","article-title":"Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease","volume":"67","author":"Aschwanden","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2016.05.002_bib0430","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1371\/journal.pone.0001452","article-title":"Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?","volume":"3","author":"Fleming","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2016.05.002_bib0435","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"issue":"Suppl. 3","key":"10.1016\/j.lpm.2016.05.002_bib0440","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000342740","article-title":"Stem cells as treatment in inflammatory bowel disease","volume":"30","author":"Hawkey","year":"2012","journal-title":"Dig Dis"},{"key":"10.1016\/j.lpm.2016.05.002_bib0445","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase\u00a02 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2016.05.002_bib0450","doi-asserted-by":"crossref","DOI":"10.1038\/nrrheum.2011.136","article-title":"Stem cells: HSCT for systemic sclerosis-swallows and summers","author":"Tyndall","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.lpm.2016.05.002_bib0455","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1212\/WNL.0000000000001329","article-title":"Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase\u00a0II trial","volume":"84","author":"Mancardi","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2016.05.002_bib0460","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/acr.20322","article-title":"Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin","volume":"63","author":"Bartoloni","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.lpm.2016.05.002_bib0465","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11926-000-0069-8","article-title":"Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease","volume":"2","author":"Wulffraat","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.lpm.2016.05.002_bib0470","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.beha.2006.09.008","article-title":"Autoimmunity following haematopoietic stem-cell transplantation","volume":"20","author":"Daikeler","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.lpm.2016.05.002_bib0475","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.bmt.1704550","article-title":"Acquired hemophilia-A in a patient with multiple sclerosis treated with autologous hematopoietic stem cell transplantation and interferon beta-1a","volume":"34","author":"Kaloyannidis","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lpm.2016.05.002_bib0480","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/bmt.2008.424","article-title":"Allogeneic hematopoietic SCT for patients with autoimmune diseases","volume":"44","author":"Daikeler","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lpm.2016.05.002_bib0485","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","article-title":"Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy","volume":"18","author":"Koc","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2016.05.002_bib0490","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2016.05.002_bib0495","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.0300-9475.2004.01483.x","article-title":"Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes","volume":"60","author":"Le Blanc","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.lpm.2016.05.002_bib0500","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrrheum.2013.166","article-title":"Mesenchymal stem cell treatments in rheumatology: a glass half full?","volume":"10","author":"Tyndall","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.lpm.2016.05.002_bib0505","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1634\/stemcells.2007-0528","article-title":"Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B\u00a0cells isolated from healthy donors and systemic lupus erythematosus patients","volume":"26","author":"Traggiai","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.lpm.2016.05.002_bib0510","doi-asserted-by":"crossref","first-page":"238","DOI":"10.7150\/ijbs.10725","article-title":"Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases?","volume":"11","author":"Huang","year":"2015","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.lpm.2016.05.002_bib0515","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fncel.2014.00377","article-title":"Exosomes\/miRNAs as mediating cell-based therapy of stroke","volume":"8","author":"Xin","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.lpm.2016.05.002_bib0520","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/annrheumdis-2013-204235","article-title":"FGF2 induces RANKL gene expression as well as IL1beta regulated MHC class\u00a0II in human bone marrow-derived mesenchymal progenitor stromal cells","volume":"74","author":"Bocelli-Tyndall","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2016.05.002_bib0525","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","article-title":"Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo","volume":"30","author":"Bartholomew","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.lpm.2016.05.002_bib0530","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/bmt.2009.63","article-title":"Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks","volume":"43","author":"Tyndall","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lpm.2016.05.002_bib0535","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.21012","article-title":"Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis","volume":"52","author":"Djouad","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2016.05.002_bib0540","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/505139a","article-title":"Leaked files slam stem-cell therapy","volume":"505","author":"Abbott","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.lpm.2016.05.002_bib0545","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/0961203309348983","article-title":"Autologous mesenchymal stem cell treatment increased T\u00a0regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients","volume":"19","author":"Carrion","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2016.05.002_bib0550","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/ard.2009.123463","article-title":"Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study","volume":"69","author":"Liang","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2016.05.002_bib0555","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/art.27548","article-title":"Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus","volume":"62","author":"Sun","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2016.05.002_bib0560","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10067-012-1943-2","article-title":"Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus erythematosus","volume":"31","author":"Shi","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2016.05.002_bib0565","article-title":"Mesenchymal\u00a0SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus","author":"Li","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lpm.2016.05.002_bib0570","doi-asserted-by":"crossref","DOI":"10.3727\/096368912X658719","article-title":"Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4\u00a0years experience","author":"Wang","year":"2012","journal-title":"Cell Transplant"},{"key":"10.1016\/j.lpm.2016.05.002_bib0575","doi-asserted-by":"crossref","first-page":"273291","DOI":"10.1155\/2012\/273291","article-title":"Double allogenic mesenchymal stem cells transplantations could not enhance therapeutic effect compared with single transplantation in systemic lupus erythematosus","volume":"2012","author":"Wang","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.lpm.2016.05.002_bib0580","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/ar4520","article-title":"Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study","volume":"16","author":"Wang","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2016.05.002_bib0585","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s10067-014-2754-4","article-title":"Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy","volume":"33","author":"Gu","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2016.05.002_bib0590","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10067-011-1816-0","article-title":"Allogeneic mesenchymal stem cells transplantation in patients with refractory RA","volume":"31","author":"Liang","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2016.05.002_bib0595","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1089\/scd.2013.0023","article-title":"Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy","volume":"22","author":"Wang","year":"2013","journal-title":"Stem Cells Develop"},{"key":"10.1016\/j.lpm.2016.05.002_bib0600","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1479-5876-9-181","article-title":"Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells","volume":"9","author":"Ra","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.lpm.2016.05.002_bib0605","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/sj.leu.2404996","article-title":"Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L","volume":"22","author":"Christopeit","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.lpm.2016.05.002_bib0610","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1002\/art.30431","article-title":"Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases","volume":"63","author":"Keyszer","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2016.05.002_bib0615","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3727\/096368912X639017","article-title":"Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis","volume":"22","author":"Scuderi","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1016\/j.lpm.2016.05.002_bib0620","article-title":"Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase\u00a0I trial","author":"Granel","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2016.05.002_bib0625","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/rheumatology\/ken407","article-title":"Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis","volume":"48","author":"Nevskaya","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2016.05.002_bib0630","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-153-10-201011160-00007","article-title":"Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report","volume":"153","author":"Guiducci","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2016.05.002_bib0635","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","article-title":"Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome","volume":"120","author":"Xu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2016.05.002_bib0640","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/rheumatology\/keu417","article-title":"Biologic treatment in Sjogren's syndrome","volume":"54","author":"Sada","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2016.05.002_bib0645","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/ard.2010.141804","article-title":"Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis","volume":"70","author":"Wang","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2016.05.002_bib0650","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3727\/096368913X667727","article-title":"Effects and safety of allogenic mesenchymal stem cell intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: a 20-week clinical trial","volume":"23","author":"Wang","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.lpm.2016.05.002_bib0655","first-page":"50","article-title":"Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study","volume":"4","author":"Mohyeddin Bonab","year":"2007","journal-title":"Iran J Immunol"},{"key":"10.1016\/j.lpm.2016.05.002_bib0660","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/1352458509104590","article-title":"Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis","volume":"15","author":"Liang","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2016.05.002_bib0665","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1479-5876-7-29","article-title":"Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis","volume":"7","author":"Riordan","year":"2009","journal-title":"J Transl Med"},{"key":"10.1016\/j.lpm.2016.05.002_bib0670","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.07.013","article-title":"Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study","volume":"227","author":"Yamout","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.lpm.2016.05.002_bib0675","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","article-title":"Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase\u00a02a proof-of-concept study","volume":"11","author":"Connick","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2016.05.002_bib0680","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","article-title":"Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase\u00a0II clinical trial","volume":"52","author":"Garcia-Olmo","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.lpm.2016.05.002_bib0685","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.2010.214841","article-title":"Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease","volume":"60","author":"Ciccocioppo","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.lpm.2016.05.002_bib0690","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/gut.2010.215152","article-title":"Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase\u00a0I study","volume":"59","author":"Duijvestein","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.lpm.2016.05.002_bib0695","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/gutjnl-2011-300083","article-title":"Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease","volume":"61","author":"Liang","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.lpm.2016.05.002_bib0700","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.2012.316","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial","volume":"307","author":"Tan","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2016.05.002_bib0705","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.arthro.2013.09.074","article-title":"Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2\u00a0years\u2019 follow-up","volume":"29","author":"Wong","year":"2013","journal-title":"Arthroscopy"},{"key":"10.1016\/j.lpm.2016.05.002_bib0710","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.2011.1670","article-title":"Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3\u00a0weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial","volume":"306","author":"Traverse","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2016.05.002_bib0715","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2012.418","article-title":"Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial","volume":"307","author":"Perin","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2016.05.002_bib0720","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2012.28726","article-title":"Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial","volume":"308","author":"Traverse","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2016.05.002_bib0725","first-page":"583","article-title":"The new avenues in the management of osteo-arthritis of knee \u2013 stem cells","volume":"108","author":"Varma","year":"2010","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.lpm.2016.05.002_bib0730","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11684-011-0116-z","article-title":"Transplantation of placenta-derived mesenchymal stem cells in type\u00a02 diabetes: a pilot study","volume":"5","author":"Jiang","year":"2011","journal-title":"Front Med"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498216301026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498216301026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T01:55:27Z","timestamp":1567994127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498216301026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0755498216301026"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2016.05.002","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cell transplantation and mesenchymal cells to treat autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.05.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.05.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.05.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.05.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.05.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.05.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.05.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.05.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.05.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}